CL-Invest is an investment company based in Oslo, Norway with a team of experts with decades of experience in project finance, assessment, and development. ​We work in partnership with National Oil Companies (NOCs) and independent oil producers to realize scalable emission reductions that can be achieved rapidly. Our mission is immediate climate action through the elimination of financial barriers with a focus on methane and flare reduction projects in emerging economies. CL-invest is presently developing several methane and flare abatement projects in Nigeria and Azerbaijan with current expansion into Iraq, Venezuela, Turkmenistan, Uzbekistan, Oman, and Iran among other countries underway. CL-Invest offers a full-service solution including project identification and assessment, project financing, implementation, verification and monitoring as well as High-Quality carbon credit development and sales. We leverage strong international partners to help manage all activities of this project cycle. The company was founded through a de-merger of Carbon Limits AS in 2021 whereby CL-Invest now subcontracts Carbon Limits to provide technical advisory and consulting services to CL-Invest and indirectly to its clients. To date, our total impact equates to 9.2 million tons of CO2e removed and approximately 70 million euros of carbon credit finance generated. Between 2022 and 2030, CL-Invest plans to initiate more than 200 projects and achieve a total carbon emission reduction equivalent to 61.4 million tCO2e. Annual estimated emission reductions on our existing projects are ​800 000 tCO2e in 2022 and 1 million tCO2e in 2023. CL-Invest is currently in the process of establishing strategic partnerships with international players who have complementary expertise and resources to assist the company in ensuring a rapid upscaling of the business. We are in the final stages of securing outside investment capital from major industry players to support our growth trajectory to be publicly announced shortly. Hence, we are now in search of a Chief Development Officer - Carbon Credits who can aid us and be the driving force in our rapid expansion.

Touchstone provides advisory in treasury & cash management. That means defining the new standards and automated ways to do day-to-day activities, from cash reconciliation to creating currency hedging strategies. Our customers are usually Group Treasurers in international organizations. Touchstone Treasury Center is a company who strives to add value to its customers in corporate treasury by providing services around three areas: 1. Advisory 2. System implementation 3. Treasury-as-a-Service (TaaS)

Chk AS is a cooperation of partners with vast commercial insights and an abundance of ambition. The service is being launched in Oslo in 2022 by Knut Alexander Staurset-Bakke. We aim to make the internet easier and more personal. We hope that people will feel comfortable using the platform. We make the internet easy, safe and personal!

In VISCAN, we provide 3D capture services and use multiple software to create interactive and immersive Digital Twins of the buildings. We help property owners and managers to make their communication and operational processes more efficient, more effective, and more sustainable. Our services can help businesses to optimize costs and carbon footprint, as well as improve onboarding, planning, marketing, and maintenance activities. We believe that by 2025 property presentations with only steel photography will be as popular as CDs today, and virtual reality devices will be as common as smartphones now. We are part of that shift, and we want to help in property digitalization not only in Norway but also in other Scandinavian countries. Metaverse needs digital assets and we help in creating them. Join us!

ELA’s mission is to provide our clients with the needed support, resources, expertise, and guidance which enables them to make the most of their own data. This contributes directly to their growth and that marks our success. We are providing the tools and latest technology that keeps our clients informed and connected.

We are currently developing a platform for creating, playing and selling quizzes.A web platform where everybody can create quizzes in many different shapes and sizes. A vault where quiz creators can get access to a huge amount to ready to use questions and answers.An APP for playing quizzes, in the classic way and in ways you did not know was possible.And maybe the most important, at marketplace where creators can publish quizzes and earn money. Like Google Play and Appstore, but just for Quizzes.

Rada Labs are bringing app ideas to life. With a big focus on creativity and innovation the company develop never seen before applications for smartphones, tablets, smart watches and computers. Rada Labs consists of creative people who love to develop high quality products and services. With innovation in focus, we develop our own brands within apps as well as develop applications for our customers. We build apps for smartphones, smartwatches, tablets and computers. By using tailored innovation processes and the latest technology in cloud services, machine learning and artificial intelligence, we can create smart applications that reach all target groups!

UNISOT is a young Norwegian start-up company and is the first global Blockchain solution based on tight integration with Enterprise Resource Planning (ERP) systems, such as SAP and other major ERP and SCM systems. Its permissionless manner will allow unprecedented abilities for secure information exchange and secure information storage to companies and/or organizations all over the world. For the first time and with the help of the open, public blockchain, UNISOT can now offer access to a reliable and secure “Universal Source of Truth” that all parties can use to handle the challenges in today’s supply chain environment, such as increased globalization, faster pace of change, global traceability, information shortage, and settlement costs, to name a few. UNISOT is leveraging the very well-established ERP Business Processes with the trust, security, immutability, and tokenization that the Open Public Permissionless Blockchain technology provides.

TracSense develops intelligent automotive solutions for the next-generation cars. Primarily the company develops and optical sensor system that can recognize slippery roads. The company's mission is to make autonomous driving possible under all weather conditions. TracSense is an ambitious start-up with its headquarters in Oslo, Norway. Have a look at our website tracsen.se/careers for our current job openings!

Grasp Your Future Our goal is to increase effectiveness and efficiency of medical treatments through person-centered care and improved clinician-patient communication. Grasp concept One-minute video presenting how Grasp works. Grasp Tracker A patented, CE-marked, and approved medical device. You simply squeeze the device when tracking your symptoms, behavior, and events. Grasp User app Through the user app, the doctor is connected to the patient´s everyday life in real-time: at home, at work, or while engaging in activities. Grasp Clinical solution The doctor can remotely and easily adjust the treatment, modify medical plans or give tailored behavioral feedback to increase the function of the patient

Zelo redefines how companies communicate internally. Streamline your internal communications by optimizing your reach. Compose, send, and track company updates across email, SMS, Teams & Slack in minutes. Use the Preferred Communication Channels Create great messages and distribute them across the channels your audience is most receptive to including email, SMS, Slack, MS Teams, and more.

CoreAll is developing game-changing core drilling technology for the E&P industry. The Intelligent Coring System includes real-time coring process control with true formation evaluation data and the ability to core and drill with the same bottom hole assembly. The system has been patented in multiple countries. The development of the main system has successfully been completed with support from Lundin Norway, Spirit Energy, DEA, The Research Council of Norway and Innovation Norway. The system has completed four successful field tests in test wells and is ready for commercial introduction. CoreAll is seeking investors to finance the commercial operations capability. CoreAll was one of only two SME winners of the prestigious Spotlight on Technology award at the OTC in Houston in May 2018.

Bookify is a nationwide search portal targeted to anyone planning meetings, events, conferences, kick-offs, and much more. With different search criteria and filters, you`ll have simple access to meetings and conference venues adapted to your standards. Quick and Easy. Bookify makes it easy to find meeting rooms, function rooms and conference rooms. We also simplify the process for people who have a suitable premise they want to rent out but do not know how to proceed. In the app you can quickly find premises near you, it is easy to find the premises that have the facilities you are looking for and payment is done seamlessly right in the app! The app uses geolocation so that you can quickly book the premises you are looking for. At the same time, you can also do more advanced searches to book ahead of time. You have a full overview of upcoming meeting rooms, payment history and receipt archives. In addition, you can add premises you use often as favorites to make the booking process even easier and faster!

The Founder Institute is the world’s premier startup launch program for talented entrepreneurs. If you are up to the challenge, our comprehensive step-by-step program will give you the structure, mentor support, and network of entrepreneurs you need to start an enduring company. Based in Silicon Valley and with chapters across 60 countries, the Founder Institute's mission is to "Globalize Silicon Valley" and build sustainable startup ecosystems worldwide.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.